Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G

Journal of Virology

Volumn 73, Issue 8, 1999, Pages 6610-6617

  Feldman, Steven A ^a   Hendry, R Michael ^b   Beeler, Judy A ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN BINDING PROTEIN; THROMBOSPONDIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEQUENCE ANALYSIS; VIRUS ADSORPTION;

EID: 0032798395     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.8.6610-6617.1999     Document Type: Article

References (52)

1. Azocar, J., and M. Essex. 1979. Incorporation of HLA antigens into the envelope of RNA tumor viruses grown in human cells. Cancer Res. 39:3388-3391.
2. Bourgeois, C., J. B. Bour, K. Lidholt, C. Gauthray, and P. Pothier. 1998. Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro. J. Virol. 72:7221-7227.
3. Byrnes, A. P., and D. E. Griffin. 1998. Binding of Sindbis virus to cell surface heparan sulfate. J. Virol. 72:7349-7356.
4. Cantin, R., J.-F. Fortin, G. Lamontagne, and M. Tremblay. 1997. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. J. Virol. 71:1922-1930.
5. Cardin, A. D., and H. J. R. Weintraub. 1989. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9:21-32.
6. Chen, Y., T. Maguire, R. E. Hileman, J. R. Fromm, J. D. Esko, R. J. Linhardt, and R. M. Marks. 1997. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3:866-871.
7. Chin, J., R. L. Magoffin, L. A. Shearer, J. H. Schieble, and E. H. Lennette. 1969. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am. J. Epidemiol. 89:449-463.
8. Collins, P. L., K. McIntosh, and R. M. Chanock. 1996. Respiratory syncytial virus, p. 1313-1351. In B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fields Virology, 3rd ed., vol. 1. Lippincott-Raven Publishers, Philadelphia, Pa.
9. Collins, P. L., and G. Mottet. 1992. Oligomerization and post-translational processing of glycoprotein G of human respiratory syncytial virus: altered O-glycosylation in the presence of brefeldin A. J. Gen. Virol. 73:849-863.
10. + T cells. J. Virol. 66:7444-7451.
11. Connors, M., A. G. Natalia, A. B. Kulkarni, C.-Y. Firestone, H. C. Morse III, and B. R. Murphy. 1994. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J. Virol. 68:5321-5325.
12. Conrad, H. E. 1998. Heparin binding proteins. Academic Press, San Diego, Calif.
13. Esko, J. D., A. Elgavish, T. Prasthofer, W. H. Taylor, and J. L. Weinke. 1986. Sulfate transport-deficient mutants of Chinese hamster ovary cells. J. Biol. Chem. 261:15725-15733.
14. Esko, J. D., T. E. Stewart, and W. H. Taylor. 1985. Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc. Natl. Acad. Sci. USA 82:3197.
15. Flynn, S. J., B. L. Burgett, D. S. Stein, K. S. Wilkinson, and P. Ryan. 1993. The amino-terminal one-third of pseudorabies virus glycoprotein gIII contains a functional attachment domain, but this domain is not required for the efficient penetration of Vero cells. J. Virol. 67:2646-2654.
16. Flynn, S. J., and P. Ryan. 1995. A heterologous heparin-binding domain can promote functional attachment of a pseudorabies virus gC mutant to cell surfaces. J. Virol. 69:834-839.
17. Gallagher, J. T., M. Lyon, and W. P. Steward. 1986. Structure and function of heparan sulfate proteoglycans. Biochem. J. 236:313-325.
18. Gorman, J. J., B. L. Ferguson, D. Speelman, and J. Mills. 1997. Determination of the disulfide bond arrangement of human respiratory syncytial virus attachment (G) protein by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Protein Sci. 6:1308-1315.
19. Hsiung, G. D. 1994. Virus assay, neutralization test, and antiviral assay, p. 46. In Hsiung's diagnostic virology, 4th ed. Yale University Press, New Haven, Conn.
20. Jackson, T., F. M. Ellard, G. R. Abu, S. M. Brookes, W. E. Blakemore, A. H. Corteyn, D. I. Stuart, J. W. I. Newman, and A. M. Q. King. 1996. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J. Virol. 70:5282-5287.
21. Johnson, P. R., M. K. Spriggs, R. A. Olmsted, and P. L. Collins. 1987. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc. Natl. Acad. Sci. USA 84:5625-5629.
22. Johnson, T. R., J. E. Johnson, S. R. Roberts, G. W. Wertz, R. A. Parker, and B. S. Graham. 1998. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge. J. Virol. 72:2871-2880.
23. Kapikian, A. Z., R. H. Mitchell, R. M. Chanock, R. A. Shvedoff, and C. E. Stewart. 1969. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:405-421.
24. Karron, R. A., D. A. Buonagurio, A. F. Georgiu, S. S. Whitehead, J. E. Adamus, M. L. Clements-Mann, D. O. Harris, V. B. Randolph, S. A. Udern, B. R. Murphy, and M. S. Sidhu. 1997. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc. Natl. Acad. Sci. USA 94:13961-13966.
25. Kim, H. W., J. G. Canchola, and C. D. E. A. Brandt. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422-434.
26. Klimstra, W. B., K. D. Ryman, and R. E. Johnston. 1998. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J. Virol. 72:7357-7366.
27. Krusat, T., and H.-J. Streckert. 1997. Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells. Arch. Virol. 142:1247-1254.
28. Langeland, N., and L. J. Moore. 1990. Reduction of HSV-1 binding to BHK cells after treatment with phosphatidylinositol-specific phospholipase C. FEBS Lett. 277:253-256.
29. Levine, S., R. Klaiber-Franco, and P. R. Paradiso. 1987. Demonstration that the glycoprotein G is the attachment protein of respiratory syncytial virus. J. Gen. Virol. 68:2521-2524.
30. Liang, X., L. A. Babiuk, and T. J. Zamb. 1993. Mapping of heparin-binding structures on bovine herpesvirus 1 and pseudorabies virus gIII glycoproteins. Virology 194:233-243.
31. Lycke, E., M. Johansson, B. Svennerholm, and U. Lindahl. 1991. Binding of herpes simplex virus to cellular heparan sulphate, an initial step in the adsorption process. J. Gen. Virol. 72:1131-1137.
32. Mbiguino, A., and J. Menezes. 1991. Purification of human respiratory syncytial virus: superiority of sucrose gradient over percoll, renografin and metrizamide gradients. J. Virol. Methods 31:161-170.
33. Mondor, I., S. Ugolini, and Q. J. Sattentau. 1998. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. J. Virol. 72:3623-3634.
34. Murphy, B. R., A. Sotnikov, L. Lawrence, S. Banks, D. Alling, and G. Prince. 1990. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization. Vaccine 8:497-502.
35. Okazaki, K., E. Honda, and Y. Kono. 1994. Heparin-binding domain of bovoid herpesvirus 1 glycoprotein gIII. Arch. Virol. 134:413-419.
36. Patel, M., M. Yanagishita, G. Roderiquez, D. C. Bou-Habib, T. Oravecz, V. C. Hascall, and M. A. Norcross. 1993. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T cell lines. AIDS Res. Hum. Retroviruses 9:167-174.
37. Roderiquez, G., T. Oravecz, M. Yanagishita, D. C. Bou-Habib, H. Mostowski, and M. A. Norcross. 1995. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. J. Virol. 69:2233-2239.
38. Satake, M., J. E. Coligan, N. Elango, E. Norrby, and S. Venkatesan. 1985. Respiratory syncytial virus envelope glycoprotein (G) has a novel structure. Nucleic Acids Res. 13:7795-7812.
39. Sawitzky, D., A. Voigt, and K.-O. Habermehl. 1993. A peptide-model for the heparin-binding property of pseudorabies virus glycoprotein gIII. Immunology 182:285-292.
40. Selvan, R. S., N. S. Ihrcke, and J. L. Platt. 1996. Heparan sulfate in immune responses. Ann. N. Y. Acad. Sci. 797:127-139.
41. Sparer, T. E., S. Matthews, T. Hussell, A. J. Rae, B. Garcia-Barreno, J. A. Melero, and P. J. M. Openshaw. 1998. Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia. J. Exp. Med. 187:1921-1926.
42. Sullender, W. M., M. A. Mufson, L. J. Anderson, and G. W. Wertz. 1991. Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses. J. Virol. 65:5425-5434.
43. Suzuki, S., A. Oldberg, E. G. Hayman, M. D. Pierschbacher, and E. Ruoslahti. 1985. Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. Eur. Mol. Biol. J. 4:2519-2524.
44. Tebbey, P. W., M. Hagen, and G. E. Hancock. 1998. Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus. J. Exp. Med. 188:1967-1972.
45. Trybala, E., T. Bergstrom, D. Spillmann, B. Svennerholm, S. Olofsson, S. J. Flynn, and P. Ryan. 1996. Mode of interaction between pseudorabies virus and heparan sulfate/heparin. Virology 218:35-42.
46. Trybala, E., T. Bergstrom, B. Svennerholm, S. Jeansson, J. C. Glorioso, and S. Olofsson. 1994. Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulfate. J. Gen. Virol. 75:743-752.
47. van Kuppevelt, T. H., M. A. B. A. Dennissen, W. J. van Venrooij, R. M. A. Hoet, and J. H. Veerkamp. 1998. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. J. Biol. Chem. 273:12960-12966.
48. Van Regenmortel, M. H. V., and A. R. Neurath (ed.). 1990. Immunochemistry of viruses II. Elsevier, Amsterdam, The Netherlands.
49. Waris, M. E., C. Tsou, D. D. Erdman, S. R. Zaki, and L. J. Anderson. 1996. Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J. Virol. 70:2852-2860.
50. Wertz, G. W., P. L. Collins, Y. Huang, C. Gruber, S. Levine, and L. A. Ball. 1985. Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. Proc. Natl. Acad. Sci. USA 82:4075-4079.
51. WuDunn, D., and P. G. Spear. 1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:52-58.
52. Zsak, L., N. Sugg, and T. Ben-Porat. 1992. The different interactions of a gIII mutant of pseudorabies virus with several different cell types. J. Gen. Virol. 73:821-827.